BioMarin Pharmaceutical
BMRN
#1829
Rank
ยฃ8.54 B
Marketcap
ยฃ44.49
Share price
-1.09%
Change (1 day)
-21.05%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2025 (TTM): ยฃ0.51 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are ยฃ3.09 Billion. In 2024 the company made an earning of ยฃ0.40 Billion, an increase over its 2023 earnings that were of ยฃ0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ0.51 B26.7%
2024 ยฃ0.40 B187.31%
2023 ยฃ0.14 B26.07%
2022 ยฃ0.11 B-298.51%
2021 -ยฃ56.73 Million78.04%
2020 -ยฃ31.87 Million-55.36%
2019 -ยฃ71.39 Million-33.56%
2018 -ยฃ0.11 Billion297.78%
2017 -ยฃ27.01 Million-95.68%
2016 -ยฃ0.63 Billion437.12%
2015 -ยฃ0.12 Billion23.91%
2014 -ยฃ94.02 Million-29.25%
2013 -ยฃ0.14 Billion49.23%
2012 -ยฃ89.05 Million171.11%
2011 -ยฃ32.85 Million103.01%
2010 -ยฃ16.18 Million-3903.54%
2009 ยฃ0.42 M-98.31%
2008 ยฃ25.16 M-189.7%
2007 -ยฃ28.06 Million51.02%
2006 -ยฃ18.58 Million-61.58%
2005 -ยฃ48.35 Million-56.59%
2004 -ยฃ0.12 Billion95.13%
2003 -ยฃ57.08 Million12.09%
2002 -ยฃ50.92 Million73.19%
2001 -ยฃ29.4 Million18.32%
2000 -ยฃ24.85 Million19.65%
1999 -ยฃ20.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
ยฃ6.85 B 1,239.71%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-ยฃ0.4 Billion-176.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-ยฃ82.09 Million-116.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-ยฃ20.66 Million-104.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
ยฃ3.75 M-99.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
ยฃ0.21 B-57.93%๐Ÿ‡บ๐Ÿ‡ธ USA